Departments of Physiology, Pharmacology and Neuroscience, West Virginia University School of Medicine, Morgantown, West Virginia.
Department of Biochemistry, West Virginia University School of Medicine, Morgantown, West Virginia.
Am J Physiol Cell Physiol. 2021 Jun 1;320(6):C1074-C1087. doi: 10.1152/ajpcell.00536.2020. Epub 2021 Apr 14.
Voltage-gated Kv7 ( family) K channels are expressed in many neuronal populations and play an important role in regulating membrane potential by generating a hyperpolarizing K current and decreasing cell excitability. However, the role of K7 channels in the neural regulation of intestinal epithelial Cl secretion is not known. Cl secretion in mouse distal colon was measured as a function of short-circuit current (I), and pharmacological approaches were used to test the hypothesis that activation of K7 channels in enteric neurons would inhibit epithelial Cl secretion. Flupirtine, a nonselective K7 activator, inhibited basal Cl secretion in mouse distal colon and abolished or attenuated the effects of drugs that target various components of enteric neurotransmission, including tetrodotoxin (Na channel blocker), veratridine (Na channel activator), nicotine (nicotinic acetylcholine receptor agonist), and hexamethonium (nicotinic antagonist). In contrast, flupritine did not block the response to epithelium-targeted agents VIP (endogenous VPAC receptor ligand) or carbachol (nonselective cholinergic agonist). Flupirtine inhibited Cl secretion in both full-thickness and seromuscular-stripped distal colon (containing the submucosal, but not myenteric plexus) but generated no response in epithelial T84 cell monolayers. K7.2 and K7.3 channel proteins were detected by immunofluorescence in whole mount preparations of the submucosa from mouse distal colon. ICA 110381 (K7.2/7.3 specific activator) inhibited Cl secretion comparably to flupirtine. We conclude that K7 channel activators inhibit neurally driven Cl secretion in the colonic epithelium and may therefore have therapeutic benefit in treating pathologies associated with hyperexcitable enteric nervous system, such as irritable bowel syndrome with diarrhea (IBS-D).
电压门控 Kv7(家族)K 通道在许多神经元群体中表达,通过产生超极化 K 电流和降低细胞兴奋性,在调节膜电位方面发挥重要作用。然而,K7 通道在肠道上皮细胞 Cl 分泌的神经调节中的作用尚不清楚。以短路电流(I)为指标测量小鼠远端结肠的 Cl 分泌,并采用药理学方法检验如下假设:肠神经元中 K7 通道的激活将抑制上皮细胞 Cl 分泌。Flupirtine 是一种非选择性 K7 激活剂,可抑制小鼠远端结肠的基础 Cl 分泌,并消除或减弱靶向各种肠神经递质成分的药物的作用,包括河豚毒素(Na 通道阻断剂)、藜芦碱(Na 通道激活剂)、烟碱(烟碱型乙酰胆碱受体激动剂)和六烃季铵(烟碱型拮抗剂)。相比之下,Flupirtine 不能阻断针对上皮细胞的 VIP(内源性 VPAC 受体配体)或卡巴胆碱(非选择性胆碱能激动剂)的反应。Flupirtine 抑制全层和肌间剥离的远端结肠(含有黏膜下但不含肌间神经丛)的 Cl 分泌,但在上皮 T84 细胞单层中没有反应。通过免疫荧光法在来自小鼠远端结肠的黏膜下全层制剂中检测到 K7.2 和 K7.3 通道蛋白。ICA 110381(K7.2/7.3 特异性激活剂)抑制 Cl 分泌的作用与 Flupirtine 相当。我们得出结论,K7 通道激活剂抑制结肠上皮细胞的神经驱动 Cl 分泌,因此在治疗与过度兴奋的肠神经系统相关的病理方面可能具有治疗益处,例如腹泻型肠易激综合征(IBS-D)。